STAT

Predatory publishers ensnare even Ivy League scientists — sometimes at taxpayers’ expense

“Predatory” publishing is a trap for scholars in the developing world — but it turns out they’re also ensnaring scientists at Harvard and Mayo Clinic.

Not long ago, Marilyn Oermann, a professor of nursing at Duke University, got an alarming email from a colleague.

The researcher in question had submitted an article to a scientific journal. Within 48 hours, she’d received a PDF of the proofs of her manuscript. No probing questions from the editor. No peer review. Just the paper, laid out and ready for publication — along with a bill for a few hundred bucks.

“She knew right away that that was a predatory journal,” said Oermann, who has done research on these kinds of shoddy publishing operations. “I told her to email saying she wasn’t going

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Brain Biopsies On ‘Vulnerable’ Patients At Mount Sinai Set Off Alarm Bells At FDA, Documents Show
A STAT Investigation: Brain biopsies on "vulnerable" patients at Mount Sinai set off alarm bells at FDA, documents show.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About CVS And Humira Biosimilars, Schumer’s Broken Insulin Promise, And More
New prescriptions for biosimilar versions of Humira, one of the best-selling drugs in the U.S., surged to 36% from just 5% during the first week of April.

Related Books & Audiobooks